Strategic Partnerships and Quarterly Financial Results Schedules - Research Report on BD, DENTSPLY, Mindray, Teleflex, and Thoratec
NEW YORK, October 23, 2013 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
Today, Analysts' Corner announced new research reports highlighting Becton, Dickinson and Co. (NYSE: BDX), DENTSPLY International Inc. (NASDAQ: XRAY), Mindray Medical International Ltd (NYSE: MR),
Teleflex Incorporated (NYSE: TFX), and Thoratec Corporation (NASDAQ: THOR). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
Becton, Dickinson and Co. Research Report
On October 16, 2013, BD Diagnostics, a segment of Becton, Dickinson and Co. (BD) along with Sartorius Stedim Biotech (SSB) announced that they have entered in a partnership to develop, manufacture and market various ready-to-use, prefilled media products for microbiological applications in pharmaceutical, biotech and research laboratories. The Company informed that as a part of this strategic partnership, BD will fill special SSB single-use products with BD culture media and supply these to SSB as prepackaged products. In addition, the two Companies are also exploring options of extending their existing business relationship by pursuing further innovative solutions in the field of microbiological diagnostics. Bob Ferguson, Vice President and General Manager, BD Diagnostics - Diagnostic Systems, Industrial Microbiology, commented, "The products we plan to develop under our agreement with Sartorius Stedim Biotech will enhance laboratory efficiencies for our pharmaceutical, biotech and research customers with these unique product offerings. By combining Sartorius Stedim Biotech's bioprocessing and filtration expertise with BD's microbiological media capabilities, customers will benefit from improved lab productivity and standardization of sample processing." The Full Research Report on Becton, Dickinson and Co. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/0175_BDX]
--
DENTSPLY International Inc. Research Report
On October 9, 2013, DENTSPLY International Inc. (DENSTPLY) announced that will report its Q3 2013 financial results on Tuesday, October 29, 2013 at 7:00 a.m. ET. The Company informed that it will also hold a conference call along with a live webcast on the same day at 8:30 a.m. ET, available at the Company website. The Company informed that its Chairman and CEO, Bret Wise, President and CFO, Chris Clark, and Executive Vice President and Chief Operating Officer, Jim Mosch will participate in the call. DENSTPLY added that a replay of the call will also be available through its website. The Full Research Report on DENTSPLY International Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/6b01_XRAY]
--
Mindray Medical International Ltd Research Report
On October 15, 2013, Mindray Medical International Ltd (Mindray) stated that it will report its Q3 2013 financial results on November 4, 2013 after the U.S. market closes. The Company informed that it will conduct a conference call the following day on November 5, 2013, 8:00 a.m. ET (9:00 p.m. Beijing/Hong Kong time) which will be hosted by Mindray's management. The Company stated that a live webcast of the call and its archive will be available at its website. The Full Research Report on Mindray Medical International Ltd - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/8d4d_MR]
--
Teleflex Incorporated Research Report
On October 16, 2013, Teleflex Incorporated (Teleflex) announced that it will release its Q3 2013 financial results on Wednesday, October 30, 2013 before market opens. The Company informed that it will also hold a conference call on the same day at 8:00 a.m. ET which can be accessed via a live audio webcast through the Teleflex's website. The Company added that an audio replay of the call will be made available from 12:00 p.m. ET, same day to November 6, 2013, 11:59 p.m. ET. The Full Research Report on Teleflex Incorporated - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/9c7d_TFX]
--
Thoratec Corporation Research Report
On October 17, 2013, Thoratec Corporation (Thoratec) announced that it will release its Q3 2013 operating results on Wednesday, October 30, 2013. The Company informed that it will also conduct a conference call on the same day at 1:30 p.m. PDT (4:30 p.m. EDT) which will be hosted by Thoratec's President and CEO, Gary F. Burbach, and Vice President and CFO, Taylor C. Harris. Thoratec stated that a live webcast of the call and its archive will be available on its website until Wednesday, November 6, 2013. The Full Research Report on Mindray Medical International Ltd - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/1bee_THOR]
----
EDITOR NOTES:
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by Namrata Maheshwari, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected].
- For any urgent concerns or inquiries, please contact us at [email protected].
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to [email protected] for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Namrata Maheshwari, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts' Corner
Share this article